| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/2009 | US20090226370 GEP, a novel chondrogenic growth factor and target in cartilage disorders |
| 09/10/2009 | DE102007046388A1 Entwicklung eines Bindungsassays und Darstellung neuartiger Inhibitoren des Myelin Assoziierten Glycoproteins Development of a binding assay and presentation of novel inhibitors of myelin-associated glycoprotein |
| 09/10/2009 | DE102004064095B4 Promotoren und deren Verwendung Promoters and their use |
| 09/09/2009 | EP2098865A1 Procedure for the detection of legionella spp using polyclonal antibodies |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098537A2 Identification of antigen- or ligand-specific binding proteins |
| 09/09/2009 | EP2098536A1 Isolation and identification of antigen- or ligand-specific binding proteins |
| 09/09/2009 | EP2098535A1 Fluorescent protein and chromoprotein |
| 09/09/2009 | EP2097532A1 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP2097526A2 Expression system of nell peptide |
| 09/09/2009 | EP2097520A1 A method for producing n-terminal methioine free polypeptides in microbial host cells |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097454A2 4-1 bb ligand in inflammatory diseases |
| 09/09/2009 | EP2097449A1 Peptides capable of binding to serum proteins |
| 09/09/2009 | EP2097446A2 Resistin antagonists and their use |
| 09/09/2009 | EP2097444A2 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 09/09/2009 | EP2097443A2 An apo-ferredoxin preparation, a process for producing same and uses thereof |
| 09/09/2009 | EP2097442A2 Methionine synthases with reduced product inhibition |
| 09/09/2009 | EP2097441A1 A polypeptide being capable of increasing the production of l-methionine, a microorganism that overexpresses said polypeptide and a process of preparing l-methionine in high yield using same |
| 09/09/2009 | EP2097439A1 Novel peptides |
| 09/09/2009 | EP2097110A2 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 09/09/2009 | EP2097108A2 Factor ix moiety-polymer conjugates having a releaseable linkage |
| 09/09/2009 | EP2097106A2 Novel uses and methods |
| 09/09/2009 | EP2097103A1 Influenza vaccine formulation |
| 09/09/2009 | EP2097100A1 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/09/2009 | EP2097096A1 Modified coagulation factors with prolonged in vivo half-life |
| 09/09/2009 | EP2097090A2 Peptide and treatment for hiv-1 infection |
| 09/09/2009 | EP2096910A2 Transgenic mammals modified bri protein expression |
| 09/09/2009 | EP1943338A4 Cell-free synthesis of membrane bound polypeptides |
| 09/09/2009 | EP1909813A4 Peptidyl diacylglycerides |
| 09/09/2009 | EP1851321B1 Hiv epitopes and pharmaceutical composition containing same |
| 09/09/2009 | EP1802653B1 Mam domain containing protein |
| 09/09/2009 | EP1734979A4 Follicle stimulating hormone superagonists |
| 09/09/2009 | EP1709179B1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 09/09/2009 | EP1654272B1 Ra antigenic peptides |
| 09/09/2009 | EP1644410B1 Sushi peptide multimer |
| 09/09/2009 | EP1578382B1 Botulinum neurotoxin b receptors and use thereof |
| 09/09/2009 | EP1548028B1 Substituted type peptides of wt1 |
| 09/09/2009 | EP1536821A4 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 09/09/2009 | EP1517918B9 Peptides having affinity for a phospholipid and uses |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1389219B1 Dimerized t-cell receptor fragment, its compositions and use |
| 09/09/2009 | EP1337555B1 Mutant bcl-2 proteins and uses thereof |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP1279735B1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 09/09/2009 | EP1181372B1 Viral expression vectors for plants |
| 09/09/2009 | EP1015488B1 Interleukin-17 receptor-like protein |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/09/2009 | CN101528773A Peptide extended insulins |
| 09/09/2009 | CN101528772A Metastin衍生物及其用途 Metastin derivatives and their use |
| 09/09/2009 | CN101528771A Method for the purification of DNAK |
| 09/09/2009 | CN101528770A Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 09/09/2009 | CN101528769A Polypeptide |
| 09/09/2009 | CN101528768A Genes and polypeptides relating to breast cancers |
| 09/09/2009 | CN101528767A Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof |
| 09/09/2009 | CN101528766A Glucanases, nucleic acids encoding them and methods for making and using them |
| 09/09/2009 | CN101525628A Processes for preparing heterologous proteins in prokaryotic host cells |
| 09/09/2009 | CN101525623A Gene of rice antibody against borers and leaf-rollers and coding product and application thereof |
| 09/09/2009 | CN101525617A Eriocheir sinensis Crustin-1 gene and in-vitro recombination expression |
| 09/09/2009 | CN101525616A Preparation and application of sperm binding protein HEL-127 specifically expressed in human epididymis |
| 09/09/2009 | CN101525615A Defensins gene expressed in human epididymis, and cloning, expression and application of same |
| 09/09/2009 | CN101525588A Protein Htp-X-P3 and method of improving enzyme heat stability by using same |
| 09/09/2009 | CN101525383A Method for inducing and extracting metallothionein of the liver of sturgeon |
| 09/09/2009 | CN101525382A Method of purifying pramlintide |
| 09/09/2009 | CN101525381A Novel recombinant consensus interferon and construction of a high-efficiency expression vector thereof |
| 09/09/2009 | CN101525380A STRAIL protein and primer thereof in crassostrea rivularis for resisting human tumor HL60 |
| 09/09/2009 | CN101525379A Plant drought-enduring associated protein, encoding gene and application thereof |
| 09/09/2009 | CN101525378A Listonella anguillarum subunit vaccine antigenic protein and application thereof |
| 09/09/2009 | CN101525373A Inhibitor of TGF-beta activation reaction |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/09/2009 | CN100537600C Enhanced proteins and methods for their use |
| 09/09/2009 | CN100537598C Substantially crystalline form of melagatran |
| 09/09/2009 | CN100536911C Peptide composition |
| 09/09/2009 | CN100536852C Application of L-FMAU for preparation of medicament for combination therapies of hepatitis b virus infection |
| 09/08/2009 | USRE40911 Canine erythropoietin gene and recombinant protein |
| 09/08/2009 | US7587286 Methods for rational pegylation of proteins |
| 09/08/2009 | US7586028 Maize variety PHR1R |
| 09/08/2009 | US7586027 Maize variety PHHMD |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585962 Gene therapy; expression of polynucleotide in nucleic acids in dopaminergic cell; Parkinson's disease |
| 09/08/2009 | US7585959 Feedback resistant acetohydroxy acid synthethase mutants |
| 09/08/2009 | US7585956 Genetic markers and polymorphisms in the bovine somatostatin (SST) locus, as well as haplotypes that are associated with certain desirable traits such as marbling |
| 09/08/2009 | US7585954 Monoclonal antibody raised by immunizing a mammal with the polypeptide CSSEVGLLKNAEREQ; binds to protein expressed in keratinocytes |
| 09/08/2009 | US7585950 Plant Myb transcription factor homologs |
| 09/08/2009 | US7585949 immune response receptor protein and ligand for use in identifying modulators for treatment of inflammation, rheumatoid arthritis, myasthenia gravis, diabetes mellitus and muscular disorders |
| 09/08/2009 | US7585948 Soluble interleukin-20 receptor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions |
| 09/08/2009 | US7585944 Toxin complex proteins and genes from Xenorhabdus bovienii |
| 09/08/2009 | US7585943 Peptide linker comprising thrombin cleavage site; enhancing recovery and purification of exogenously expressed polypeptides |
| 09/08/2009 | US7585942 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 09/08/2009 | US7585941 Regulation of the MOR-1 splice variant activities may impact the physiologic process of analgesia |
| 09/08/2009 | US7585940 Comprises at least any 16 amino acid mutations at any of the sequence positions 25, 26, 27, 28, 29, 30, 31, 32, 33, 56, 57, 58, 83, 105, 106, 108 and 109 of the linear polypeptide sequence of the mature wild-type form; with detectable affinity |